The global wearable
injectors market is predicted to register significant growth in the
coming years. This is attributed to the increasing demand for advanced drug
delivery, rising geriatric population, and surging prevalence of chronic
diseases. A device which is utilized for delivering large volume of drugs over
an extended period of time is referred to as a wearable injector. The device
delivers large subcutaneous doses of drugs to patients even when the patient is
ambulatory and is able to carry out normal daily life activities during the
drug delivery.
In terms of end user, the wearable injectors market is
categorized into lab & diagnostics, home care, hospital, and others (which
include small clinics and healthcare settings). Out of these, the home care
category dominated the market in the past and is expected to account for the
major share of the market in the near future as well due to the growing demand
for self-injection system. On the basis of technology, the market is classified
into mechanical injector, electronic injector, and others (which include
hydrogel and hydraulic injector).
Another key driving factor of the wearable injectors
market is the increasing requirement for innovative drug delivery. Infusion
therapy costs around $35 billion in the specialty drug market, according to
Unilife Corporation. The utilization of advanced drug delivery devices,
including wearable injectors at home, decreases the overall healthcare cost, as
the patients can take the drugs themselves with minimal or no training.
Furthermore, these drug delivery devices are being preferred by different
healthcare setups, including labs & diagnostics and clinics, as they are
cheaper than other controlled drug delivery devices.
Hence, the market is being driven by the increasing
geriatric population and rising need for advanced drug delivery
